Clinical Trials Logo

Genetic Predisposition clinical trials

View clinical trials related to Genetic Predisposition.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06413082 Completed - Hypertension Clinical Trials

Pharmacogenetics of Torasemide and Spironolactone in Hypertension Treatment

ALTUM
Start date: February 15, 2021
Phase: Phase 3
Study type: Interventional

Phase III interventional study to evaluate the different efficacy of Torasemide and Spironolactone in reducing systolic blood pressure in carriers and non-carriers of the different genotypic combinations for Lanosterol and Uromodulin

NCT ID: NCT06402266 Completed - Clinical trials for Genetic Predisposition

Simultaneous tDCS and Computerised Gamified Short-term Memory Task Feasibility

ACTTDCS-FG
Start date: July 4, 2022
Phase:
Study type: Observational

The goal of this observational study is to gain insight into the effects of transcranial direct current stimulation (tDCS) on short-term memory task performance and the feasibility of tDCS in overtly healthy carriers of the susceptibility allele, Apolipoprotein (APOE) ε4, for late-onset Alzheimers disease. The main questions the study aims to answer are: - If tDCS is feasible in overtly healthy APOE ε4 carriers using a headset and an app-based short-term memory task. - If overtly healthy APOE ε4 carriers perform better on a complex short-term memory task when receiving tDCS to the right hemisphere (F4 à PZ) compared to the left hemisphere (F3 à PZ) or sham tDCS. Participants will be asked to complete an app-based short-term memory task while receiving either tDCS to either the right or left hemisphere or sham stimulation on 3 different days spread out over 1-3 weeks.

NCT ID: NCT06212310 Completed - Clinical trials for Genetic Predisposition

Genetic Counseling Service Delivery and Outcomes in Diverse and Underserved Populations

Start date: February 1, 2022
Phase: N/A
Study type: Interventional

This 2-arm prospective, randomized, controlled clinical trial compared outcomes of telephone genetic counseling (intervention) versus in-person genetic counseling (control) in an underserved, multilingual patient population referred for cancer genetic counseling at two North Texas safety-net hospitals. The main question[s] it aims to answer are: - Is telephone genetic counseling equal to in-person genetic counseling in the patient reported outcomes? Cancer genetics knowledge, attitude towards GT, and informed choice as well as GC-specific empowerment. - Is telephone genetic counseling-based clinical outcomes the same as in-person genetic counseling for visit completion and testing rates? Participants will be randomized to either in-person or telephone genetic counseling arm and complete standard of care genetic counseling visit process where testing is offered. Both arms will complete a series of surveys to assess the outcomes of interest.

NCT ID: NCT05975489 Completed - Clinical trials for Genetic Predisposition

Genetics in the Effect of Caffeine on Fat Oxidation

Start date: October 1, 2020
Phase: N/A
Study type: Interventional

Genetic polymorphism on the effect of oral caffeine intake on fat oxidation during exercise has been studied in active and healthy population performing an incremental test on a cycle ergometer with 3-min stages at workloads from 30 to 70% of maximal oxygen uptake (VO2max). Participants performed this test after the ingestion of a) placebo; b) 3 mg/kg of caffeine; c) 6 mg/kg of caffeine. Fat oxidation rate during exercise was measured by indirect calorimetry. The influence of the CYP1A2 c.-163A>C, GSTP c.313A>G and PGC1a polymorphisms was evaluated to determine the effects on fat oxidation during exercise

NCT ID: NCT05771454 Completed - Breast Cancer Clinical Trials

Frequency of Occult Breast Cancer After Prophylactic Mastectomy Among High-Penetrance Breast Cancer Gene Positives

OBC-PM
Start date: January 1, 2023
Phase:
Study type: Observational

The role of Sentinel Lymph Node Biopsy(SLNB) among mutation-negative BC patients is well established; however, we are lacking data to assess the role of sentinel lymph node biopsy for patients who are undergoing surgery for prophylactic reasons without proven malignancy. Literature has reported a positive Occult Breast Cancer (OBC) rate of 0 to 11.3% among mastectomy specimens which are removed prophylactically. Majority of the time when the invasive focus is diagnosed in prophylactic mastectomy specimens they are found to be in-situ cases where axillary Staging using SLNB can be exempted; however, when the OBC is identified even in prophylactic mastectomy specimens, axilla should be addressed accordingly. Albeit SLNB has associated complications with it; postoperative pain, lymphedema, paresthesia and rare reaction to the injected dye. Therefore the question here arises regarding skipping SLNB among patients who are undergoing PRRMs without proven malignancy pre-operatively. However, before standardizing the practice in our population we need convincing evidence that the frequency of OBC is low among our patients. By identifying the true prevalence of OBC among our gene-positive HBC patients who are opting for PRRM, we would be able to skip SLNB; as not only it has psychological implications but also adds a financial burden on patients and families due to the addition of an extra procedure and hospital bills; as the financial and socioeconomic status of our population has already declined over last few years due to the economic crises faced worldwide, specifically after-affects are seen in Lower Middle-Income Country(LMIC) like Pakistan.

NCT ID: NCT05334355 Completed - Clinical trials for Genetic Predisposition

Impact of a Family History of Hypertension and Physical Activity on Left Ventricular Mass

Start date: April 19, 2016
Phase:
Study type: Observational

This is a retrospective analysis of data collected within two previous studies. The data has been combined and used to investigate the impact of having a family history of hypertension on left ventricular muscle mass with and without controlling for moderate and vigorous intensity physical activity frequency per week. The hypothesis was that in a sample of mostly active participants, no differences in left ventricular mass between family history of hypertension groups would be observed, but the positive family history of hypertension group would have elevated left ventricular mass compared to the negative family history of hypertension group following statistical control of activity frequency.

NCT ID: NCT05220969 Completed - Clinical trials for Genetic Predisposition

Total Genotype Score, Growth, Maturation and Loading Exposure as Risk Factors for Injury in Elite Male Youth Football

Start date: December 1, 2019
Phase:
Study type: Observational

A total genotype risk score was generated based on the findings of previous research for non-contact injury, non-contact muscle injury, tendon injury, ligament injury, fracture injury and apophysitis injury. This score was then compared with the incidence of injury between those with high, medium and low risk scores for each injury. The influence of different rates of growth, stages of physical maturation and loading exposure were then also included in the risk model to see if any interaction effects could be observed between genetic risk score and susceptibility to injury in different categories of growth, maturation and loading exposure.

NCT ID: NCT04955002 Completed - Psychological Clinical Trials

Food Choice, Psychological Bias, and Genetic Predisposition

Start date: June 9, 2021
Phase:
Study type: Observational

This project aims to assess if food choice is impacted by loss aversion (LA), and if this differs based on genetic predisposition to LA, in a UK healthy cohort.

NCT ID: NCT04746794 Completed - Clinical trials for Genetic Predisposition

Early Detection of GEnetic Risk (EDGE)

Start date: September 25, 2020
Phase: N/A
Study type: Interventional

The study intervention involves having patients complete a familial cancer risk assessment survey. Those who are found to be at high risk will be offered genetic testing for a panel of hereditary cancers. A "previvor" plan will be created to assist patients and their providers in completing the appropriate follow-up for those with a mutation identified.

NCT ID: NCT04446754 Completed - Health Behavior Clinical Trials

The Genetic Effects of rs7903146 and Dietary Intake on Type 2 Diabetes Mellitus Risk in a Healthy Population

Start date: April 10, 2019
Phase:
Study type: Observational

This study investigates the association of genetic effects of rs7903146 and dietary intake on type 2 Diabetes Mellitus (T2DM) risk in a healthy population. T2DM risk was assessed through glycated haemoglobin (HbA1c) concentration in 73 subjects. Dietary intake was assessed using a validated food frequency questionnaire (FFQ).